[SEIP-AEPAP-SEPEAP consensus document on the aetiology, diagnosis and treatment of bacterial skin infections in out-patients]

An Pediatr (Barc). 2016 Feb;84(2):121.e1-121.e10. doi: 10.1016/j.anpedi.2015.01.002. Epub 2015 Feb 27.
[Article in Spanish]

Abstract

Skin infections are a common cause for dermatological consultations in the paediatric setting. A review is presented of the clinical manifestations, diagnosis and treatment of the main bacterial skin infections, as well as the diagnosis and treatment of super-infected puncture and bite wounds. The most prevalent bacteria in skin infections are Staphylococcus aureus and Streptococcus pyogenes. Treatment is usually empirical, since microbiological studies are only recommended under certain circumstances or lack of improvement with common therapies. Superficial skin infections can be treated with local antiseptics or antibiotics (mupirocin or fusidic acid). Systemic treatment is usually reserved for patients with extensive or severe disease or with other risk factors. Systemic treatment depends on the suspected infecting bacteria, with penicillin, amoxicillin, amoxicillin-clavulanic acid and first or second generation cephalosporin being the most frequently used drugs. Due to the low incidence of community-acquired methicillin-resistant infection by S. aureus in Spain, the use of clindamycin or co-trimoxazole is only recommended after severe disease, relapses or a clear epidemiological background.

Keywords: Bacterial skin infections; Infecciones cutáneas bacterianas; Staphylococcus aureus; Streptococcus pyogenes; Tratamiento; Treatment.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Clindamycin / therapeutic use
  • Community-Acquired Infections / drug therapy
  • Consensus
  • Humans
  • Outpatients
  • Pediatrics
  • Spain
  • Staphylococcal Skin Infections / diagnosis*
  • Staphylococcal Skin Infections / therapy*
  • Staphylococcus aureus
  • Streptococcal Infections / diagnosis*
  • Streptococcal Infections / therapy*
  • Streptococcus pyogenes

Substances

  • Anti-Bacterial Agents
  • Clindamycin